April 2011
Volume 52, Issue 14
ARVO Annual Meeting Abstract  |   April 2011
Norrin Mediates Its Protective Properties Against Oxygen-induced Retinal Damage By Induction Of IGF-1 Expression
Author Affiliations & Notes
  • Andreas Ohlmann
    Dept. of Anatomy,
    University of Regensburg, Regensburg, Germany
  • Ludwig F. Zeilbeck
    Dept. of Anatomy,
    University of Regensburg, Regensburg, Germany
  • Thomas Langmann
    Dept. of Human Genetics,
    University of Regensburg, Regensburg, Germany
  • Ernst R. Tamm
    Dept. of Anatomy,
    University of Regensburg, Regensburg, Germany
  • Footnotes
    Commercial Relationships  Andreas Ohlmann, None; Ludwig F. Zeilbeck, None; Thomas Langmann, None; Ernst R. Tamm, None
  • Footnotes
    Support  Supported by DFG Forschergruppe 1075.
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 3982. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Andreas Ohlmann, Ludwig F. Zeilbeck, Thomas Langmann, Ernst R. Tamm; Norrin Mediates Its Protective Properties Against Oxygen-induced Retinal Damage By Induction Of IGF-1 Expression. Invest. Ophthalmol. Vis. Sci. 2011;52(14):3982.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: : To analyze if norrin, a secreted protein that controls capillary formation in the developing retina and protects from vascular damage after oxygen-induced retinopathy (OIR) via the Wnt/(beta)-catenin pathway, mediates its function, at least partially, by induction of insulin-like growth factor (IGF)-1.

Methods: : Human dermal microvascular endothelial cells (HDMEC) and rat Mueller cells were incubated with Norrin and/or Dickkopf (DKK)-1, an inhibitor of the canonical Wnt/(beta)-catenin signaling pathway. The expression of IGF-1 was analyzed by quantitative real-time RT-PCR and western blotting. In parallel experiments, transgenic mice with an ocular overexpression of Norrin ((beta)B1-Norrin; Ohlmann et al., J. Neurosci. 2005, 2010) were investigated for retinal IGF-1 mRNA expression during retinal development and after induction of OIR following incubation with 75% oxygen from postnatal day (P) 7 to P12. In addition, an inhibitory anti-IGF-1 antibody was injected into the vitreous body of oxygen-treated mice at P12 and sizes of vasoobliterated areas were measured at P14.

Results: : In both HDMEC and Mueller cells that had been treated with 20 ng/ml Norrin, a significant induction of IGF-1 mRNA was detected when compared to untreated controls. When higher concentrations were used, IGF-1 expression was less prominent, indicating dose dependency of Norrin treatment. Comparable results were observed regarding the amounts of IGF-1 synthesized in HDMEC or Mueller cells. After an additional treatment of the cells with DKK-1, the Norrin-mediated effects on IGF-1 expression were blocked almost completely.During development of the eye, only minor changes in IGF-1 mRNA expression were detected in retinae from (beta)B1-Norrin mice when compared to wild type littermates. However, after induction of OIR, IGF-1 mRNA levels increased substantially in transgenic mice at P13. In oxygen-treated transgenic mice with an injection of inhibitory anti-IGF-1 antibodies into the vitreous cavity at P12, a significant increase in vasoobliterated retinal areas was observed at P14.

Conclusions: : Norrin induces the expression of IGF-1 via an activation of the classical Wnt/(beta)-catenin pathway in vitro and in vivo. The protective effects of Norrin against OIR are mediated, at least partially, via the induction of IGF-1.

Keywords: retinopathy of prematurity • growth factors/growth factor receptors • signal transduction 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.